WCN'24 Plenary Session 2: CrispCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria)

WCN'24 Plenary Session 2: CrispCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? (Obiageli Eunice Nnodu, Nigeria)

Obiageli Eunice Nnodu

Nigeria

Key:

Complete
Failed
Available
Locked
CrispCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture
Open to view video.
Open to view video.
You must register to access.